- Global Pharma News & Resources

Transplant Diagnostics Market is expected to reach USD 2,074.7 million with a CAGR of 7.81% by 2023

Global Transplant Diagnostics Market is expected to reach USD 2,074.7 million by 2023 at a CAGR of 7.81% from 2018 to 2023.

The global transplant diagnostics market studies the overall dynamics and trends of the market in terms of various segments and regional outlook for the period of 2017 to 2023. The report offers of historic and future market scenario in terms of market value, share and critical developments taking place in the industry. Market size, forecast, trends of each country and region are studied in the report for the focus period of 2017 to 2023.

We can provide sample pages for a better understanding of this report.
Request Sample of This Report @

Qualitative assessment tools such as PEST analysis, cost structure analysis and regulatory compliance for pharmaceutical products are offered in the report. The report also comprises Pipeline Analysis which helps understand the comprehensive forecast scenario of the market in terms of value and dynamics. The report analyses the recent drug approval trends and market dynamics such as drivers, restrains, and opportunities, industry trends and future outlook in the global transplant diagnostics market.

The report represents key players operating in the market along with its competitive landscape. The competitive landscape includes player positioning analysis, competitive matrix and market share analysis of the key players operating in the industry. The market attractive index highlights the most lucrative regional market to invest in the market.

The market is studied for regions such as North America (U.S., and Canada), Europe (U.K., Germany, France, Spain, and Rest of Europe), Asia Pacific (China, Japan, India, South Korea, Australia, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America) and Middle East amp; Africa (GCC, South Africa, and Rest of Middle East amp; Africa).

Key Takeaways:

What is the market size in 2017 and the growth rate of the global transplant diagnostics market?

What is the market drivers, restrains, opportunities governing the global transplant diagnostics market?

Which are the largest and the fastest growing segments in the global transplant diagnostics market?

Who are the key players operating in the market and their market position?

What is the pipeline scenario, drug pricing analysis and technological development in the market?

View Detail Report With Complete Table Of Content@

Transplant diagnostic is a test which is performed during organ transplantation to identify the compatibility of the organ. It is a medical procedure in which an organ is removed from one body and placed in another to swap the damaged or missing organ. The transplant diagnostic test is mainly performed to reduce the risk of organ rejection. Organ transplantation is performed to treat organ failures such as lungs, liver, kidney, and many more. The rising incidence of chronic and infectious diseases, increasing awareness related to transplant diagnostic procedures, and growing number of stem cell, soft-tissue, and solid organ transplantations are projected to drive market growth over the forecast period.

However, strict regulatory bodies and stringent regulatory policies are expected to restrain market growth during the forecast period.
The global transplant diagnostics market has been segmented, by product and service, screening type, organ type, application type, and end user.
Based on product and service, the global transplant diagnostics market has been categorized as instruments, reagents and consumables, and software and services.
On the basis of screening type, the global transplant diagnostics market is further sub-segmented into pre-transplant screening and post-transplant screening.
By organ type, the global transplant diagnostics market is further sub-segmented into kidney, liver, heart, lung, pancreas, and others.
On the basis of application type, the global transplant diagnostics market is further sub-segmented into research application, diagnostics applications, and others.
On the basis of end user, the market has been classified as commercial services providers, hospitals and transplant centers, research laboratories, and academics institutes and others.

The global transplant diagnostics market was valued at USD 1,326.4 million in 2017 and is expected to register a CAGR of 7.81% during the forecast period from 2018 to 2023.

Key Players

Some of the key players in the global transplant diagnostics market are Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc, F. Hoffmann-La Roche AG, Qiagen N.V, BioMeacute;rieux SA, Illumina, Inc, Becton, Dickinson and Company, Caredx, Inc, Gendx, Zimmer Biomet, Medtronic PLC, DiaSorin S.P.A, Merck KGaA, and Immucor, Inc.

Objectives of the Study

To provide a detailed analysis of the market structure along with a forecast of various segments and sub-segments of the global transplant diagnostics market
To provide insights into factors influencing and affecting market growth
To provide historical and forecast revenue of market segments and sub-segments with respect to countries
To provide strategic profiling of key players in the market and comprehensively analyzing their market share, core competencies, and drawing a competitive landscape for the market
To provide economic factors that influence the global transplant diagnostics market
To provide a detailed analysis of the value chain and supply chain of the global transplant diagnostics market

Target Audience

Research and Development (Ramp;D) Companies
Academic Institutes and Universities
Pharmaceutical Companies
Raw Material Suppliers
Suppliers and Distributors
Transplant Diagnostics Kits Manufacturers
Potential Investors

Key Findings

The global transplant diagnostics market is expected to reach USD 2,074.7 million by 2023 at a CAGR of 7.81% from 2018 to 2023
Based on products and services, the reagents and consumables segment holds the largest market share and is expected to reach USD 1,027.54 million by 2023 at a CAGR of 8.4% from 2018 to 2023
The market in the Americas is expected to account for the largest share of the global transplant diagnostics market and is projected to reach USD 666.78 million by 2023
The transplant diagnostics market in Asia-Pacific is projected to be the fastest-growing at a CAGR of 8.52% from 2018 to 2023

Regional Analysis


North America
Latin America


Western Europe

Rest of Western Europe

Eastern Europe


South Korea
Rest of Asia-Pacific

Middle East amp; Africa

Middle East

Few Significant from Table Of Contents

Global Transplant Diagnostics Market- Forecast 2023

1 Report Prologue

2 Executive Summary

3 Market Introduction
3.1 Scope of Study
3.2 Research Objective
3.3 List of Assumptions
3.4 Market Structure

4 Research Methodology
4.1 Primary Research Methodology
4.2 Data points received from the Specialist Doctors:
4.3 Data points received from the Manufacturer/ Pharmaceutical Companies:
4.4 Data points received from Hospitals, Diagnostic Centers:
4.5 Secondary Research Methodology
4.6 Market Share Analysis
4.7 Trade Analysis
4.8 Market Pricing Approach
4.9 Forecast Model

5 Market Dynamics
5.1 Introduction
5.2 Drivers
5.2.1 Growing number of stem cell, soft-tissue, and solid organ, transplantation procedures
5.2.2 Rising occurrence of chronic and infectious diseases
5.2.3 Increasing Awareness Related to Transplant Diagnostic Procedures
5.3 Restraints
5.3.1 Shortage of donor organ and limited medical reimbursement
5.3.2 High cost of NGS- and PCR-based devices
5.4 Opportunities
5.4.1 High demand for tissue engineering in cosmetic and reconstructive surgery
5.4.2 Growing geriatric population presents a significant growth opportunity

6 Market Factor Analysis
6.1 Porters Five Forces Analysis
6.1.1 Bargaining Power of Suppliers
6.1.2 Bargaining Power of Buyers
6.1.3 Threat of New Entrants
6.1.4 Threat of Substitutes
6.1.5 Intensity of Rivalry
6.2 Supply Chain Analysis
6.2.1 Primary activities
6.2.2 Secondary Activities

7 Immunosuppressant Drug Monitoring (ISD)
7.1 Overview
7.1 Diagnostic Tests for Transplantation
7.1.1 Therapeutic Drug Monitoring During Transplantation
7.2 Americas
7.2.1 North America U.S. Canada
7.2.2 South America
7.3 Europe
7.3.1 Germany
7.3.2 U.K
7.3.3 France
7.3.4 Spain
7.3.5 Italy
7.3.6 Rest of Europe
7.4 Asia Pacific
7.4.1 China
7.4.2 Japan
7.4.3 India
7.4.4 Australia
7.4.5 Rest of Asia Pacific
7.5 Middle East amp; Africa
7.5.1 Middle East
7.5.2 Africa

8 Global Transplant Diagnostics Market, By Products and Services
8.1 Introduction
8.1.1 Instruments
8.1.2 Reagents amp; Consumables
8.1.3 Software and Services

9 Global Transplant Diagnostics Market, By Screening Type
9.1 Introduction
9.1.1 Pre-Transplant Screening
9.1.2 Post-Transplant Screening

10 Global Transplant Diagnostics Market, By Organ Type
10.1 Introduction
10.1.1 Kidney
10.1.2 Liver
10.1.3 Heart
10.1.4 Lung
10.1.5 Pancreas

11 Global Transplant Diagnostics Market, By Application Type
11.1 Introduction
11.1.1 Research Applications
11.1.2 Diagnostic Applications

12 Global Transplant Diagnostics Market, By End User
12.1 Introduction
12.1.1 Commercial Service Providers
12.1.2 Hospitals and Transplant Centres
12.1.3 Research Laboratories and Academic Institutes

13 Global Transplant Diagnostics Market, By Region
13.1 Introduction
13.2 Americas
13.2.1 North America U.S. Canada
13.2.2 South America
13.3 Europe
13.3.1 Germany
13.3.2 U.K
13.3.3 France
13.3.4 Spain
13.3.5 Italy
13.3.6 Rest of Europe
13.4 Asia Pacific
13.4.1 China
13.4.2 Japan
13.4.3 India
13.4.4 Australia
13.4.5 Rest of Asia Pacific
13.5 Middle East amp; Africa
13.5.1 Middle East
13.5.2 Africa

14 Competitive Landscape
14.1 Company Market Share Analysis
14.1.1 Introduction
14.2 Competitive Landscape
14.2.1 Introduction
14.3 Key Developments

15 Company Profiles
15.1 Thermo Fisher Scientific Inc.
15.1.1 Company Overview
15.1.2 Financial Overview
15.1.3 Products Offering
15.1.4 Key Developments
15.1.5 SWOT Analysis
15.1.6 Key Strategy
15.2 Bio-Rad Laboratories, Inc.
15.2.1 Company Overview
15.2.2 Financial Overview
15.2.3 Products Offering
15.2.4 Key Developments
15.2.5 SWOT Analysis
15.2.6 Key Strategy
15.3 F. Hoffmann-La Roche AG
15.3.1 Company Overview
15.3.2 Financial Overview
15.3.3 Products Offering
15.3.4 Key Developments
15.3.5 SWOT Analysis
15.3.6 Key Strategy
15.4 Qiagen N.V.
15.4.1 Company Overview
15.4.2 Financial Overview
15.4.3 Products Offering
15.4.4 Key Developments
15.4.5 SWOT Analysis
15.4.6 Key strategy
15.5 BioMeacute;rieux SA
15.5.1 Company Overview
15.5.2 Financial Overview
15.5.3 Products Offering
15.5.4 Key Developments
15.5.5 SWOT Analysis
15.5.6 Key Strategy
15.6 Illumina, Inc.
15.6.1 Company Overview
15.6.2 Financial Overview
15.6.3 Products Offering
15.6.4 Key Developments
15.6.5 SWOT Analysis
15.6.6 Key Strategy
15.7 Becton, Dickinson and Company
15.7.1 Company Overview
15.7.2 Financial Overview
15.7.3 Products Offering
15.7.4 Key Developments
15.7.5 SWOT Analysis
15.7.6 Key Strategy
15.8 Caredx, Inc.
15.8.1 Company Overview
15.8.2 Financial Overview
15.8.3 Products Offering
15.8.4 Key Developments
15.8.5 SWOT Analysis
15.8.6 Key Strategy
15.9 Gendx
15.9.1 Company Overview
15.9.2 Financial Overview
15.9.3 Products Offering
15.9.4 Key Developments
15.9.5 SWOT Analysis
15.9.6 Key Strategy
15.1 Zimmer Biomet
15.10.1 Company Overview
15.10.2 Financial Overview
15.10.3 Products Offering
15.10.4 Key Developments
15.10.5 SWOT Analysis
15.10.6 Key Strategy
15.11 Medtronic PLC
15.11.1 Company Overview
15.11.2 Financial Overview
15.11.3 Products Offering
15.11.4 Key Developments
15.11.5 SWOT Analysis
15.11.6 Key Strategy
15.12 DiaSorin S.P.A
15.12.1 Company Overview
15.12.2 Financial Overview
15.12.3 Products Offering
15.12.4 Key Developments
15.12.5 SWOT Analysis
15.12.6 Key Strategy
15.13 Merck KGaA
15.13.1 Company Overview
15.13.2 Financial Overview
15.13.3 Products Offering
15.13.4 Key Developments
15.13.5 SWOT Analysis
15.13.6 Key Strategy
15.14 Immucor, Inc.
15.14.1 Company Overview
15.14.2 Financial Overview:
15.14.3 Products Offering
15.14.4 Key Developments
15.14.5 SWOT Analysis
15.14.6 Key strategy

16 Appendix
16.1 Discussion Blue Print
16.2 Reference

Quick Buy This Premium Report From Here:

About Us:

Ameco Research is the one spot destination for all your research needs. Ameco Research holds the repository of quality research reports from numerous publishers across the globe. Our inventory of research reports caters to various industry verticals including Healthcare, Information and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc. With the complete information about the publishers and the industries they cater to for developing market research reports, we help our clients in making a purchase decision by understanding their requirements and suggesting best possible collection matching their needs.


Email: | +1 407 915 4157

Editor Details

Last Updated: 28-Jun-2019